SQUAWK/NEWS
Account
Theme
Account
Menu
Live News MACRO FLASH L impact

FDA Selects Mission: Cure to Develop Pancreatitis Trial Endpoint

Mission: Cure joins the FDA’s Rare Disease Endpoint Advancement Pilot Program to develop a pancreatitis flare endpoint for clinical trials.

Related stories